Equities analysts predict that Aurora Cannabis Inc. (NYSE:ACB – Get Rating) will post sales of $39.11 million for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Aurora Cannabis’ earnings, with the lowest sales estimate coming in at $38.05 million and the highest estimate coming in at $41.25 million. Aurora Cannabis posted sales of $44.63 million during the same quarter last year, which suggests a negative year-over-year growth rate of 12.4%. The company is scheduled to report its next quarterly earnings results on Monday, January 1st.
According to Zacks, analysts expect that Aurora Cannabis will report full-year sales of $171.51 million for the current financial year, with estimates ranging from $169.33 million to $174.92 million. For the next financial year, analysts expect that the business will post sales of $178.28 million, with estimates ranging from $158.82 million to $212.42 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that cover Aurora Cannabis.
Several brokerages recently weighed in on ACB. CIBC dropped their price target on shares of Aurora Cannabis from C$6.50 to C$3.75 in a research report on Monday, May 16th. Zacks Investment Research raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Monday, January 31st. Finally, Cantor Fitzgerald dropped their target price on shares of Aurora Cannabis from C$7.60 to C$3.90 in a research report on Friday, May 13th. Three equities research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $5.74.
Shares of NYSE ACB opened at $2.68 on Thursday. Aurora Cannabis has a fifty-two week low of $2.20 and a fifty-two week high of $10.64. The stock has a market cap of $601.20 million, a price-to-earnings ratio of -0.58 and a beta of 2.86. The company has a debt-to-equity ratio of 0.32, a quick ratio of 3.70 and a current ratio of 5.85. The firm’s 50-day simple moving average is $3.31 and its 200 day simple moving average is $4.57.
Aurora Cannabis Company Profile (Get Rating)
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
- Get a free copy of the StockNews.com research report on Aurora Cannabis (ACB)
- Short-Covering Begins In Big Lots
- Agilent Technologies Is Bottoming But Don’t Buy It Yet
- Institutions Ring The Register On Toll Brothers Stock
- Dick’s Sporting Goods Falls Flat On Weak Guidance
- Indie Semiconductor Stock is Putting in a Bottom
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.